What is the treatment for tissue epidermal necrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment for tissue epidermal necrosis involves a conservative approach with regular cleansing of wounds and intact skin using warmed sterile water or saline, and application of a greasy emollient and topical antimicrobial agent as needed, as recommended by the most recent guidelines 1. The goal of treatment is to promote healing, prevent infection, and minimize scarring.

  • Regular cleansing of wounds and intact skin is essential to remove bacteria and debris, and can be done using warmed sterile water or saline, or an antimicrobial such as chlorhexidine (1/5000) 1.
  • Application of a greasy emollient, such as 50% white soft paraffin with 50% liquid paraffin, over the whole epidermis, including denuded areas, can help to protect the skin and promote healing 1.
  • Topical antimicrobial agents, such as silver-containing products or dressings, can be applied to sloughy areas to prevent infection, but should be used judiciously due to the risk of absorption 1.
  • Nonadherent dressings, such as Mepitel or Telfa, can be applied to denuded dermis to protect the wound and promote healing, and a secondary foam or burn dressing can be used to collect exudate 1. In cases of extensive epidermal loss (> 30% BSA), consideration should be given to transfer to a burn centre for specialized care, including surgical debridement and physiological closure with biosynthetic dressings 1. It is also important to address the underlying cause of the necrosis, whether it's a drug reaction, infection, or other factor, and to provide supportive care, including pain management and nutritional support, to promote healing and prevent complications 1.

From the Research

Treatment for Tissue Epidermal Necrosis

The treatment for tissue epidermal necrosis, also known as toxic epidermal necrolysis (TEN), involves a combination of topical and systemic therapies. The primary goal of treatment is to promote wound healing, prevent infection, and manage symptoms.

  • Topical Treatment: Topical treatments are essential in managing TEN, including specific bedding, debridement of epidermal necrosis, applications of bioactive skin substitutes or semi-synthetic and synthetic dressings, as well as antiseptic and antibiotic agents 2.
  • Debridement: Debridement is the removal of necrotic material, scabs, and devitalized tissues, which is an essential element of wound healing therapy. Properly performed debridement leads to improvement of microcirculation in the wound, reduction in inflammation, and lowering of the level of metalloproteinases 3.
  • Antimicrobial Agents: Antimicrobial agents, such as creams and ointments, are used to prevent infection and promote wound healing. These agents can be used in conjunction with surgical intervention or as a non-operative wound care approach 4.
  • Systemic Therapy: Immunomodulating systemic therapy may be necessary in some cases of TEN, particularly in severe cases or those with significant mucosal involvement 5.
  • Wound Care: Wound care procedures must be managed according to the skin condition, corresponding to the initial highly exudating/necrotic phase, the secondary moderately exudating stabilized phase, and the later re-epidermization phase. Bedding modalities, debridement procedures, applications of bioactive, semi-synthetic, and synthetic dressings, and antiseptic/antibiotic creams should be adapted accordingly 2.

Diagnosis and Treatment Approach

A fast and accurate diagnosis of TEN is crucial for relevant treatment decision. Ex vivo confocal laser scanning microscopy (CLSM) offers a rapid and reliable approach for morphological TEN emergency screening on fresh skin samples 6. The S3 guideline provides an evidence-based framework for the diagnosis and treatment of epidermal necrolysis, including Stevens-Johnson syndrome and toxic epidermal necrolysis 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.